160 related articles for article (PubMed ID: 19320847)
1. siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines.
Miyake M; Ishii M; Kawashima K; Kodama T; Sugano K; Fujimoto K; Hirao Y
Photochem Photobiol; 2009; 85(4):1020-7. PubMed ID: 19320847
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy.
Frank J; Lornejad-Schäfer MR; Schöffl H; Flaccus A; Lambert C; Biesalski HK
Int J Oncol; 2007 Dec; 31(6):1539-45. PubMed ID: 17982681
[TBL] [Abstract][Full Text] [Related]
3. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
[TBL] [Abstract][Full Text] [Related]
4. Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells.
Tsai T; Hong RL; Tsai JC; Lou PJ; Ling IF; Chen CT
Lasers Surg Med; 2004; 34(1):62-72. PubMed ID: 14755426
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity.
Hefti M; Holenstein F; Albert I; Looser H; Luginbuehl V
Photochem Photobiol; 2011; 87(1):235-41. PubMed ID: 21073472
[TBL] [Abstract][Full Text] [Related]
6. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy.
Ishizuka M; Abe F; Sano Y; Takahashi K; Inoue K; Nakajima M; Kohda T; Komatsu N; Ogura S; Tanaka T
Int Immunopharmacol; 2011 Mar; 11(3):358-65. PubMed ID: 21144919
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
[TBL] [Abstract][Full Text] [Related]
8. Roles of porphyrin and iron metabolisms in the δ-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin and photodamage of tumor cells.
Ohgari Y; Miyata Y; Miyagi T; Gotoh S; Ohta T; Kataoka T; Furuyama K; Taketani S
Photochem Photobiol; 2011; 87(5):1138-45. PubMed ID: 21668870
[TBL] [Abstract][Full Text] [Related]
9. Deletion of alloantigen-activated cells by aminolevulinic acid-based photodynamic therapy.
Hryhorenko EA; Oseroff AR; Morgan J; Rittenhouse-Diakun K
Photochem Photobiol; 1999 May; 69(5):560-5. PubMed ID: 10333761
[TBL] [Abstract][Full Text] [Related]
10. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
[TBL] [Abstract][Full Text] [Related]
11. ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells.
Tsai T; Ji HT; Chiang PC; Chou RH; Chang WS; Chen CT
Lasers Surg Med; 2009 Apr; 41(4):305-15. PubMed ID: 19347942
[TBL] [Abstract][Full Text] [Related]
12. Modulation and proteomic changes on the heme pathway following treatment with 5-aminolevulinic acid.
Sansaloni-Pastor S; Varesio E; Lange N
J Photochem Photobiol B; 2022 Aug; 233():112484. PubMed ID: 35671620
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.
Iinuma S; Bachor R; Flotte T; Hasan T
J Urol; 1995 Mar; 153(3 Pt 1):802-6. PubMed ID: 7861543
[TBL] [Abstract][Full Text] [Related]
14. Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment. Laboratory investigation.
Etminan N; Peters C; Ficnar J; Anlasik S; Bünemann E; Slotty PJ; Hänggi D; Steiger HJ; Sorg RV; Stummer W
J Neurosurg; 2011 Aug; 115(2):281-8. PubMed ID: 21513432
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
Inoue K; Fukuhara H; Kurabayashi A; Furihata M; Tsuda M; Nagakawa K; Fujita H; Utsumi K; Shuin T
Cancer Sci; 2013 Jun; 104(6):765-72. PubMed ID: 23480042
[TBL] [Abstract][Full Text] [Related]
16. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.
Teng L; Nakada M; Zhao SG; Endo Y; Furuyama N; Nambu E; Pyko IV; Hayashi Y; Hamada JI
Br J Cancer; 2011 Mar; 104(5):798-807. PubMed ID: 21304523
[TBL] [Abstract][Full Text] [Related]
17. In vitro resistance of articular chondrocytes to 5-Aminolevulinic acid based photodynamic therapy.
Egli RJ; Di Criscio A; Hempfing A; Schoeniger R; Ganz R; Hofstetter W; Leunig M
Lasers Surg Med; 2008 Apr; 40(4):282-90. PubMed ID: 18412230
[TBL] [Abstract][Full Text] [Related]
18. Predictive biomarkers for 5-ALA-PDT can lead to personalized treatments and overcome tumor-specific resistances.
Mastrangelopoulou M; Grigalavicius M; Raabe TH; Skarpen E; Juzenas P; Peng Q; Berg K; Theodossiou TA
Cancer Rep (Hoboken); 2022 Dec; 5(12):e1278. PubMed ID: 32737955
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy using direct-current pulsed iontophoresis for 5-aminolevulinic acid application.
Mizutani K; Watanabe D; Akita Y; Akimoto M; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):280-2. PubMed ID: 19747250
[TBL] [Abstract][Full Text] [Related]
20. [Use of 5-aminolevulinic acid in photochemotherapy and fluorescence diagnostics].
Moan J; Bech O; Peng Q; Berg K
Tidsskr Nor Laegeforen; 1998 Mar; 118(8):1206-11. PubMed ID: 9567698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]